zetomipzomib
zetomipzomib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kezar Life Sciences, Inc. (KZR) | Phase 2 |
Clinical Trials (1)
A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With Open-label Extension to Evaluate the Safety and Efficacy of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis
Frequently asked questions
Who is developing zetomipzomib?
zetomipzomib is being developed by Kezar Life Sciences, Inc..
How many clinical trials involve zetomipzomib?
BioSniper tracks 1 clinical trial involving zetomipzomib.
Get deeper analysis on zetomipzomib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis